XOLAIR

Serial Number 79250398
Registration 5809618
739

Registration Progress

Application Filed
Oct 30, 2018
Under Examination
Approved for Publication
May 7, 2019
Published for Opposition
May 7, 2019
Registered
Jul 23, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-07-23) (Grace Period Filing)
Due: Jan 23, 2026 Grace Period - 171 days
Original deadline was Jul 23, 2025 (overdue)

Trademark Image

XOLAIR

Basic Information

Serial Number
79250398
Registration Number
5809618
Filing Date
October 30, 2018
Registration Date
July 23, 2019
Published for Opposition
May 7, 2019
Drawing Code
3

Status Summary

Current Status
Active
Status Code
739
Status Date
Jun 27, 2025
Registration
Registered
Classes
005

Ownership History

Novartis AG

Original Applicant
25
CH

Novartis AG

Owner at Publication
25
CH

Novartis AG

Original Registrant
25
CH

Legal Representation

Attorney
Maury M. Tepper, III

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-07-23)
Due Date
July 23, 2025
Grace Period Ends
January 23, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Jun 27, 2025 NA75 E NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Loading...
Jun 27, 2025 C75A O REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. Loading...
Jun 26, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Mar 14, 2025 ES75 I TEAS SECTION 71 & 15 RECEIVED Loading...
Jul 23, 2024 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Aug 12, 2021 RNWL P INTERNATIONAL REGISTRATION RENEWED Loading...
Nov 30, 2019 FINV P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Nov 13, 2019 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Nov 13, 2019 FIMP P FINAL DISPOSITION PROCESSED Loading...
Oct 23, 2019 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jul 23, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 7, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 7, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 17, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 14, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 7, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 7, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 7, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 6, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 6, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 1, 2019 RFNT P REFUSAL PROCESSED BY IB Loading...
Feb 14, 2019 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Feb 14, 2019 RFRR P REFUSAL PROCESSED BY MPU Loading...
Feb 6, 2019 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Feb 5, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 5, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 2, 2019 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jan 29, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 28, 2019 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Jan 24, 2019 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of severe allergic reactions following exposure to an allergen

Additional Information

Design Mark
The mark consists of the wording "XOLAIR" with the crossbar of the "X" extending over the wording to form an arch, and the dot over the "I" formed by a three armed propeller shape.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005